A0A346FLH4 (A0A346FLH4_HUMAN) Homo sapiens (Human)
MHC class II antigen UniProtKBInterProInteractive Modelling
Available Structures
25 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structure of human invariant chain in complex with HLA-DQ |
Heteromer P01909; P01920; P04233; | 100.0 | 3×NAG; | |||
| HLA-DQ2.5-alpha2 gliadin peptide in complex with DQN0344AE02 |
Heteromer O19712; P01909; | 99.45 | 2×NAG; | |||
| Bel602-DQ8.5-glia-gamma1 complex |
Heteromer A0A0B4J274; A0A0U5Q247; A0A580; A0A5B9; P01848; P01909; P08079; | 99.45 | 1×NAG; 1×CA; | |||
| Crystal structure of HLA-DQ2.5-CLIP1 at 2.73 resolution |
Heteromer P01909; P04233; Q5Y7D3; | 100 | ||||
| DQ2-P.fluor-alpha1a |
Heteromer O19712; P01909; | 99.45 | 2×NAG; 2×GOL; 1×PO4; | |||
| HLA-DQ2-glia-alpha1 |
Heteromer O19712; P01909; | 100 | 1×NAG; | |||
| Structure of the MHC class II molecule HLA-DQ8 bound with a deamidated gluten peptide |
Heteromer P01909; P01920; P18573; | 92.27 | ||||
| HLA-DQ2.5-B/C hordein peptide in complex with DQN0385AE02 |
Heteromer O19712; P01909; | 99.45 | 1×NAG; | |||
| 3C11-DQ2-glia-a2 complex |
Heteromer P01909; Q5Y7D3; | 100 | 1×NAG; 1×NAG; 1×NAG; 7×IPA; 3×CL; | |||
| JR5.1 protein complex |
Heteromer P01850; P01909; P04722; Q2YD82; Q5Y7D3; | 100 | 2×NAG; | |||
| S16 protein complex |
Heteromer P01850; P01909; P04722; Q2YD82; Q5Y7D3; | 100 | 2×NAG; 1×CA; | |||
| LS2.8/3.15 - DQ2-P.fluor-alpha1a complex |
Heteromer O19712; P01909; | 99.45 | 1×NAG; | |||
| T15-DQ8.5-glia-gamma1 complex |
Heteromer A0A0B4J274; A0A0U5Q247; A0A580; A0A5B9; P01848; P01909; P08079; | 99.45 | 1×NAG; 2×NAG; | |||
| D2 protein complex |
Heteromer P01850; P01909; P04722; Q2YD82; Q5Y7D3; | 100 | 1×NAG; | |||
| Protein complex |
Heteromer K7N5N2; P01850; P01909; P01920; P18573; | 92.74 | 2×NAG; | |||
| S2 protein complex |
Heteromer P01850; P01909; P04722; Q2YD82; Q5Y7D3; | 100 | 1×NAG; 1×CA; | |||
| Crystal structure of HLA-DQ2.5-CLIP2 |
Heteromer P01909; P04233; Q5Y7D3; | 100 | ||||
| Crystal structure of a human insulin peptide-HLA-DQ8 complex |
Heteromer P01308; P01909; P01920; | 92.22 | 1×NAG; | |||
| HLA-DQ2-glia-omega1 |
Heteromer O19712; P01909; | 100 | 2×NAG; | |||
| HLA-DQ2.5-gamma2 gliadin peptide in complex with DQN0385AE01 |
Heteromer O19712; P01909; | 99.44 | 1×NAG; | |||
| W316 TCR in complex with HLA-DQ2-omega1 |
Heteromer O19712; P01909; | 100 | 2×NAG; 3×EDO; | |||
| XPA5 TCR in complex with HLA-DQ2-alpha1 |
Heteromer P01909; Q5Y7D3; | 100 | 1×NAG; 1×EDO; 2×CA; | |||
| Crystal structure of HLA-DQ2 complexed with deamidated gliadin peptide |
Heteromer P01909; P01920; | 100 | 2×EDO; | |||
| HLA-DQ2.5-alpha1 gliadin peptide in complex with DQN0344AE02 |
Heteromer O19712; P01909; | 99.44 | 1×NAG; | |||
| XPA5 TCR in complex with HLA-DQ2-omega1 |
Heteromer P01909; Q5Y7D3; | 100.0 | 1×NAG; 1×EDO; 1×ACT; 2×CA; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8vsp.1.A | monomer | 0.75 | 100.00 | |||
| 7yx9.1.B | monomer | 0.62 | 21.26 | |||